Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery.


Journal

NPJ vaccines
ISSN: 2059-0105
Titre abrégé: NPJ Vaccines
Pays: England
ID NLM: 101699863

Informations de publication

Date de publication:
08 Aug 2023
Historique:
received: 07 11 2022
accepted: 12 07 2023
medline: 9 8 2023
pubmed: 9 8 2023
entrez: 8 8 2023
Statut: epublish

Résumé

While several COVID-19 vaccines have been in use, more effective and durable vaccines are needed to combat the ongoing COVID-19 pandemic. Here, we report highly immunogenic self-assembling SARS-CoV-2 spike-HBsAg nanoparticles displaying a six-proline-stabilized WA1 (wild type, WT) spike S6P on a HBsAg core. These S6P-HBsAgs bound diverse domain-specific SARS-CoV-2 monoclonal antibodies. In mice with and without a HBV pre-vaccination, DNA immunization with S6P-HBsAgs elicited significantly more potent and durable neutralizing antibody (nAb) responses against diverse SARS-CoV-2 strains than that of soluble S2P or S6P, or full-length S2P with its coding sequence matching mRNA-1273. The nAb responses elicited by S6P-HBsAgs persisted substantially longer than by soluble S2P or S6P and appeared to be enhanced by HBsAg pre-exposure. These data show that genetic delivery of SARS-CoV-2 S6P-HBsAg nanoparticles can elicit greater and more durable nAb responses than non-nanoparticle forms of stabilized spike. Our findings highlight the potential of S6P-HBsAgs as next generation genetic vaccine candidates against SARS-CoV-2.

Identifiants

pubmed: 37553406
doi: 10.1038/s41541-023-00707-w
pii: 10.1038/s41541-023-00707-w
pmc: PMC10409857
doi:

Types de publication

Journal Article

Langues

eng

Pagination

111

Subventions

Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States

Informations de copyright

© 2023. Springer Nature Limited.

Références

Clin Infect Dis. 2015 Feb 15;60(4):505-13
pubmed: 25389254
Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149
pubmed: 32747721
Front Immunol. 2021 Feb 26;12:637654
pubmed: 33732258
J Infect Dis. 2016 Jul 1;214(1):16-22
pubmed: 26802139
N Engl J Med. 2022 Apr 7;386(14):1377-1380
pubmed: 35297591
Proc Natl Acad Sci U S A. 2022 Aug 30;119(35):e2110105119
pubmed: 35994646
PLoS One. 2022 Aug 30;17(8):e0273712
pubmed: 36040882
mSphere. 2022 Aug 31;7(4):e0024322
pubmed: 35968964
Front Immunol. 2021 Jul 12;12:701501
pubmed: 34322129
Sci Transl Med. 2021 May 12;13(593):
pubmed: 33820835
Lancet Microbe. 2021 Jul;2(7):e279-e280
pubmed: 33899038
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
Nat Rev Drug Discov. 2021 Jun;20(6):414
pubmed: 33981089
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
BMJ. 2022 Mar 9;376:e069761
pubmed: 35264324
Viruses. 2020 Jan 21;12(2):
pubmed: 31973017
Nat Med. 2022 May;28(5):1063-1071
pubmed: 35189624
Science. 2021 Aug 13;373(6556):
pubmed: 34210892
Sci Rep. 2020 Oct 23;10(1):18149
pubmed: 33097791
J Struct Biol. 2007 Jan;157(1):38-46
pubmed: 16859925
Nature. 2020 Oct;586(7830):567-571
pubmed: 32756549
Science. 2022 Nov 25;378(6622):eabo2523
pubmed: 36302057
Structure. 2022 Sep 1;30(9):1233-1244.e7
pubmed: 35841885
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S343-S351
pubmed: 34590138
Sci Transl Med. 2022 Aug 17;14(658):eabq4130
pubmed: 35976993
Front Immunol. 2018 Oct 04;9:2224
pubmed: 30337923
Nat Commun. 2022 Aug 4;13(1):4539
pubmed: 35927266
J Immunol. 1998 Jan 15;160(2):870-6
pubmed: 9551923
NPJ Vaccines. 2021 May 13;6(1):70
pubmed: 33986287
Sci Adv. 2022 Mar 18;8(11):eabl6015
pubmed: 35294244
Science. 2020 Sep 18;369(6510):1501-1505
pubmed: 32703906
N Engl J Med. 2021 Dec 9;385(24):e84
pubmed: 34614326
Cell Rep. 2021 Dec 21;37(12):110143
pubmed: 34919799
Science. 2020 Sep 25;369(6511):1586-1592
pubmed: 32694201
Nature. 2021 Jun;594(7864):553-559
pubmed: 33971664
Science. 2022 Apr 22;376(6591):eabn8897
pubmed: 35324257
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Vaccine. 1991 Feb;9(2):97-100
pubmed: 1829306
Cell Rep. 2020 Oct 27;33(4):108322
pubmed: 33091382
J Biol Chem. 2021 Oct;297(4):101127
pubmed: 34461095
Nat Commun. 2020 Jul 17;11(1):3618
pubmed: 32681106
Science. 2016 Oct 14;354(6309):237-240
pubmed: 27708058
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
N Engl J Med. 2022 Mar 17;386(11):1091-1093
pubmed: 35081294
Cell Host Microbe. 2020 Dec 9;28(6):867-879.e5
pubmed: 33271067
World J Clin Cases. 2018 Nov 6;6(13):589-599
pubmed: 30430114
J Infect. 1986 Jul;13 Suppl A:39-45
pubmed: 2943814
Science. 2021 Sep 17;373(6561):1372-1377
pubmed: 34385356
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Cuiping Liu (C)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Lingshu Wang (L)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Jonah S Merriam (JS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Wei Shi (W)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Eun Sung Yang (ES)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Yi Zhang (Y)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Man Chen (M)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Wing-Pui Kong (WP)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Cheng Cheng (C)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Yaroslav Tsybovsky (Y)

Vaccine Research Center Electron Microscopy Unit, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.

Tyler Stephens (T)

Vaccine Research Center Electron Microscopy Unit, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.

Raffaello Verardi (R)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Kwanyee Leung (K)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Cody Stein (C)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Adam S Olia (AS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Darcy R Harris (DR)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Misook Choe (M)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Baoshan Zhang (B)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Barney S Graham (BS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Peter D Kwong (PD)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA.

Richard A Koup (RA)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA. rkoup@mail.nih.gov.

Amarendra Pegu (A)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA. pegua@niaid.nih.gov.

John R Mascola (JR)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA. jmascola.nih@icloud.com.

Classifications MeSH